Preliminary results of a phase II study of nivolumab with hypofractionated re-radiation and bevacizumab for recurrent MGMT methylated glioblastoma Meeting Abstract

  

Authors:	Grommes, C.; Mehta, M.; Miller, A.; Daras, M.; Piotrowski, A.; Boire, A.; Butler, B.; Stone, J.; Pentsova, E.; Kotecha, R.; Morrison, T.; Odia, Y.; Mellinghoff, I.; Beal, K.
Abstract Title:	Preliminary results of a phase II study of nivolumab with hypofractionated re-radiation and bevacizumab for recurrent MGMT methylated glioblastoma
Meeting Title:	25th Virtual Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology
Journal Title:	Neuro-Oncology
Volume:	22
Issue:	Suppl. 2
Meeting Dates:	2020 Nov 19-21
Meeting Location:	Virtual Conference
ISSN:	1522-8517
Publisher:	Oxford University Press
Date Published:	2020-11-01
Start Page:	ii36
Language:	English
ACCESSION:	WOS:000590061300150
PROVIDER:	wos
DOI:	10.1093/neuonc/noaa215.149
Notes:	Meeting Abstract: CTIM-15 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/175553